We are live on ! Find out more
LMIM

Lockheed Martin Investment Management Portfolio holdings

AUM $2.73B
1-Year Est. Return 28.24%
This Fund
S&P 500
This Quarter Est. Return
+4.48%
1 Year Est. Return
+28.24%
3 Year Est. Return
+67.58%
5 Year Est. Return
+76.13%
10 Year Est. Return
+215.14%
AUM
$1.89B
AUM Growth
+$64.8M
Cap. Flow
-$11.8M
Cap. Flow %
-0.62%
Top 10 Hldgs %
61.58%
Holding
148
New
18
Increased
26
Reduced
39
Closed
17

Top Buys

Rank Stock Value
1
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$84.6M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$35.1M
3
EUFN icon
iShares MSCI Europe Financials ETF
EUFN
+$10.1M
4
VGK icon
Vanguard FTSE Europe ETF
VGK
+$7.37M
5
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$5.12M

Top Sells

Rank Stock Value
1
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$27.3M
2
NVS icon
Novartis
NVS
+$13M
3
UN
Unilever NV New York Registry Shares
UN
+$10.1M
4
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$9.07M
5
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$8.88M

Sector Composition

Rank Sector Weight
1 Technology 3.87%
2 Financials 3.17%
3 Communication Services 1.92%
4 Healthcare 1.37%
5 Consumer Discretionary 0.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMBA icon
126
Ambarella
AMBA
$3.77B
$529K 0.03%
10,800
-10,800
-50% -$533K
EVH icon
127
Evolent Health
EVH
$348M
$510K 0.03%
28,650
– –
DXCM icon
128
DexCom
DXCM
$31.5B
$387K 0.02%
31,600
-38,000
-55% -$672K
MA icon
129
Mastercard
MA
$502B
$339K 0.02%
+2,400
New +$318K
GILD icon
130
Gilead Sciences
GILD
$162B
$324K 0.02%
+4,000
New +$306K
TEVA icon
131
Teva Pharmaceuticals
TEVA
$40.8B
$317K 0.02%
+18,000
New +$405K
AZN icon
132
AstraZeneca
AZN
$263B
– –
-73,900
Closed -$5.04M
BSX icon
133
Boston Scientific
BSX
$69.5B
– –
-137,000
Closed -$3.8M
BTI icon
134
British American Tobacco
BTI
$131B
– –
-116,200
Closed -$7.96M
BUD icon
135
AB InBev
BUD
$170B
– –
-47,700
Closed -$5.26M
CMA
136
DELISTED
Comerica
CMA
– –
-23,500
Closed -$1.72M
DEO icon
137
Diageo
DEO
$49B
– –
-39,100
Closed -$4.68M
ELV icon
138
Elevance Health
ELV
$81.5B
– –
-3,500
Closed -$658K
GSK icon
139
GSK
GSK
$104B
– –
-115,120
Closed -$6.21M
HAL icon
140
Halliburton
HAL
$26.9B
– –
-24,000
Closed -$1.02M
NVO
141
Novo Nordisk
NVO
$208B
– –
-219,000
Closed -$4.7M
NVS icon
142
Novartis
NVS
$297B
– –
-174,208
Closed -$13M
NWL icon
143
Newell Brands
NWL
$2.38B
– –
-19,000
Closed -$1.02M
SNY icon
144
Sanofi
SNY
$103B
– –
-139,300
Closed -$6.67M
STX icon
145
Seagate
STX
$194B
– –
-92,000
Closed -$3.56M
SYK icon
146
Stryker
SYK
$125B
– –
-9,000
Closed -$1.25M
WDC icon
147
Western Digital
WDC
$188B
– –
-29,768
Closed -$1.99M
UN
148
DELISTED
Unilever NV New York Registry Shares
UN
– –
-183,500
Closed -$10.1M
2 3 4 5
6

Similar funds

GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $2.72B AUM 36.56% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return

Lockheed Martin Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Lockheed Martin Investment Management held 148 positions worth $1.89B, up 3.6% from $1.82B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Lockheed Martin Investment Management's Q3 2017 filing shows 18 new, 26 increased, 39 reduced and 17 closed positions. Its largest new stake was Visa: 27,515 shares worth $2.9M. The largest sale was State Street Consumer Staples Select Sector SPDR ETF, an estimated $27.3M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, down from 4.1% a quarter earlier, followed by Financials and Communication Services.

  • Lockheed Martin Investment Management's largest Q3 2017 buy was Visa: 27,515 shares worth $2.9M.
  • Lockheed Martin Investment Management added most to State Street Energy Select Sector SPDR ETF in Q3 2017, an estimated $84.6M increase.
  • Lockheed Martin Investment Management's biggest Q3 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $27.3M.
  • Lockheed Martin Investment Management fully exited Novartis in Q3 2017, selling an estimated $13M.
  • Lockheed Martin Investment Management's ten largest holdings make up 62% of its $1.89B portfolio in Q3 2017.
  • Lockheed Martin Investment Management opened 18 new positions and closed 17 in Q3 2017.
  • Lockheed Martin Investment Management's portfolio value rose 3.6% quarter-over-quarter to $1.89B.

Based on Lockheed Martin Investment Management's 13F filing for Q3 2017, filed 6 Nov 2017.